Katherine Eade, JD

Katherine Eade is Chief Legal Officer of Kriya. She is an independent board member for Harvard Bioscience and is the chairperson of the Governance committee and a member of both the Audit and Compensation committees. Katherine joined Kriya after serving as a consulting General Counsel and advisor to biopharma companies for fundraising, corporate governance, board matters, and BD and licensing opportunities. Prior to this, Katherine was General Counsel of Checkmate Pharmaceuticals & President of Checkmate Pharmaceuticals Security Corp. where, along with leading legal, IP and compliance, she negotiated strategic agreements including co-leadership of the sale of Checkmate to Regeneron Pharmaceuticals. In the decade prior to joining Checkmate, Katherine served in various legal leadership roles, including VP of Strategic Commercial Affairs at Align Technology, Director of M&A Law & Transactions at Corning Incorporated, and Division Counsel of Corning Life Sciences and Corning Pharmaceutical Technologies. Katherine began her legal career as an attorney at Cleary Gottlieb, a leading international law firm, and served as a law clerk to Judge Morton I. Greenberg of the U.S. Court of Appeals for the Third Circuit. Katherine received a JD from Harvard Law School and a BA from Cornell University.